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Background: The population of the elderly is increasing, as is the number of people suffering from 
neurodegenerative diseases. Since the cause of those diseases is unknown, there is no appropriate 
medical treatment. The purpose of this systematic review is to present papers on consumption of 
certain foods, supplements or introduction of dietary restrictions that promote healthy brain aging or 
possibly delay the onset of disease. 
Methods: The PubMed, ScienceDirect, and SpringerLink databases were used for the research. 24 
studies with a total number of 10 445 participants were selected as satisfying the final criteria. 
Results: Mediterranean diet, dietary supplements and natural nutrients with recently discovered 
pharmacological properties are of interest to numerous scientists. 
Conclusion: Since the results of the studies are inconsistent, we concluded that a large, carefully 
controlled long-term interventional study would be required in order to investigate the effect of 
nutrition on prevention of disease and cognitive decline.  
(Šeper V, Nešić N. Nutrition Patterns in Prevention and Treatment of Neurodegenerative Diseases: 
Alzheimer’s Disease. SEEMEDJ 2019; 3(1); 42-49) 
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Introduction 
The number of people who are over 65 is 
growing and it is estimated that said age group 
will constitute up to 30% of the entire world 
population by the end of 2050. Aging includes 
changes to all organs and body systems, as well 
as to the brain. In 2001, there were 24 million 
people in the world older than 60 and suffering 
from dementia. It is estimated that this number 
will double every twenty years and that by the 
end of 2040 80 million people will be suffering 
from it (1). The economic burden of care and 
treatment of neurodegenerative diseases also 
increases the need for seeking measures for 
prevention or reversing of age-related disorders 
(2). A neurodegenerative age-related disease 
like Alzheimer’s (AD) appears to be the 
consequence of stress and of the same 
environmental factors that are responsible for 
the aging of other organs and body systems. The 
clear cause of the disease is still unknown, but 
some key changes, including 
membrane/synaptic degeneration and 
abnormal protein processing resulting in the 
formation of amyloid-β plaques and 
neurofibrillary tangles, have been detected (3). 
Oxidative stress and inflammation are thought to 
play a significant role in the early stage of the 
disease, forming a vicious circle of damaging the 
sensitive brain cells. Epidemiological studies 
point out that anti-inflammatory, antioxidant and 
neuroprotective agents found in food or plants 
may have a positive effect by strengthening the 
neuronal antioxidant defence. The 
Mediterranean diet has also been linked with a 
lower incidence of neurodegenerative diseases 
such as AD (4). Neurodegenerative diseases 
cannot be prevented using specific medication 
or treatment, so identifying a new natural 
compound with pharmacological properties is 
the subject of interest to a large number of 
scientists. Chronic neurodegenerative diseases 
like AD and Parkinson’s disease are related to 
obesity and diabetes, not just in the developing 
countries, but in the developed countries as 
well. Dietary restrictions, including a diet low in 
saturated fats, cholesterol and carbohydrates 
and the consumption of berries, nuts and 
neuroprotective plant supplements, might have 
a positive effect on healthy brain functioning (5, 
6). 
Burgener et al. (2008) state that some people 
live to be 90 and have adequate cognitive 
functioning while some develop symptoms of 
AD in their late 50s. The difference might be due 
to interaction between genetics and 
environment (1). Since we cannot fully affect 
genetics, this review will focus on actions 
promoting healthy brain aging and possible 
delay of the onset of the disease, including the 
consumption of certain foods, supplementation 
and introduction of dietary restrictions. 
Methods  
Literature research took place in January 2018. 
Databases used in the search were PubMed, 
ScienceDirect and SpringerLink. Keywords 
neurodegenerative diseases, prevention, 
Mediterranean diet, nutrition, supplementation 
were entered to identify papers dealing with 
neurodegenerative diseases and nutrition. The 
PubMed database yielded 2 articles. Another 102 
articles were found after using the option “similar 
results” with the first paper and 98 articles were 
found for the second paper. 
Inclusion Criteria 
All articles containing the terms Alzheimer’s 
disease, neurodegenerative diseases, dementia, 
cognitive decline, mild, Mediterranean diet, 
nutrition, vitamin B, C, E, D, antioxidants, 
supplementation, MUFAs, PUFAs, ω-3, ω-6, 
olive oil, prevention, cohort, prospective in the 
title or abstract were included in the review. If 
terms physical activity, cancer, cardiovascular 
diseases, respiratory problems, drugs appeared 
in the title or abstract of the article, they were 
excluded. Other exclusion criteria were if a paper 
included animal research (dogs, rats), if it tested 
medicinal dietary supplements or if it could not 
be fully accessed. 
The criteria were ultimately met by 24 articles 
regarding studies conducted on 10 445 
participants. 
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Results The final results obtained after applying filters 
are shown in Table 1.   
 
Table 1. PubMed search methodlogy and results 




98 new articles 
from 2000 until 2018 97 98 
on humans 92 96 
English language 85 87 
persons 65+ 16 21 
review of abstracts and title of the articles 
based on including criteria 
8 7 
 
The same keywords were used to search the 
ScienceDirect database and 430 articles were 
identified initially. This number was narrowed to 
372 after setting the timeframe to include 
articles published from 2009 to 2018. The 
number of articles was further reduced to 69 by 
using the option “type of article – research” and 
to 11 by using the option “publication title”. They 
were published in the journals Clinical Nutrition, 
Alzheimer’s & Dementia and Food Research 
International. After reading the titles and 
abstracts, 4 articles were selected.  
The above-mentioned keywords were used for 
searching the SpringerLink database, where 264 
articles were identified. After applying the filter 
article, the initial number was reduced to 177 and 
then to 23 after using the filter “biomedicine”. 
Further restriction of results was accomplished 
using the options “Neurosciences and English”, 
which led to 10 articles. Titles and abstracts were 
reviewed, and 3 articles were selected. 
 
Discussion 
Neurodegenerative diseases and nutrition 
Dry matter in the brain mostly consists of fat, 20% 
of which is made up of ω-3 and ω-6 
polyunsaturated fatty acids, which significantly 
influence the structure and composition of the 
neuronal membrane. Adequate nutrition is the 
source of those acids. Aging brings changes in 
the taste and smell of food, the basal metabolic 
rate decreases, and due to possible swallowing 
impairment and impaired digestion, dietary 
intake is also reduced. Unsaturated fatty acids 
and vitamins are thus in deficit. Neuronal 
membrane lipids change and influence 
homeostasis necessary for membrane fluidity 
and function, as well as for prevention of loss of 
synaptic plasticity, apoptosis and 
neurodegeneration (3). Since the cause of 
neurodegenerative diseases is still unknown, 
numerous researchers have made speculations 
regarding the connection between dietary 
habits, food intake and aging as the possible link 
for prevention or delay of the onset of 
neurodegenerative diseases, especially AD (7). 
Particular attention was given to diets such as 
the Mediterranean diet, food supplements and 
introduction of dietary restrictions. 
Mediterranean diet 
Notably, there are few published studies dealing 
with primary or secondary prevention of AD 
through nutritional interventions. Most of them 
have focused on the effects of single nutrient 
supplementation (3). However, studies should 
focus on the entire dietary pattern and not just 
on a single nutrient in order to avoid neglecting 
important interactions between food 
components since people do not eat only single 
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nutrients (7). After analysing a number of dietary 
patterns, the Mediterranean diet was selected. 
This type of diet is characterized by 
consumption of fruit and vegetables, legumes, 
fish and complex carbohydrates on a daily basis. 
Olive oil is the main source of fat, and moderate 
drinking of red wine at meals is recommended 
(7). One of the first studies linking the 
Mediterranean diet to a lower risk of developing 
AD was conducted in 2006 in New York on 2258 
non-demented participants. After 4 years of 
follow-up, the results showed that higher 
adherence to this type of diet lowers the risk of 
developing AD, which indicates that that such 
diet may have a protective effect (8). Anther 
cohort study, the Washington Heights/Hamilton 
Heights Columbia Aging Project (WHICAP) 
conducted in 2012 on 1219 non-demented 
people, found that higher levels of ω-3 
polyunsaturated fatty acids from fish, poultry, 
nuts and margarine were significantly 
associated with lower levels of plasma Aβ42, 
which suggests that they play an important role 
in lowering the risk of AD and slowing cognitive 
decline (9). Consumption of at least 100 grams of 
olive oil per day as one of the sources of 
polyphenols also slows cognitive decline (1). 
Morris et al. (2015) studied the connection 
between the MIND diet, a hybrid of the 
Mediterranean diet, and the occurrence of AD. 
The MIND diet contained 15 nutrients, 9 of which 
were linked to healthy brain aging (leafy greens, 
nuts, berries, legumes, whole grains, fish, 
poultry, olive oil, red wine) and 6 to unhealthy 
brain aging (red meat, margarine, cheese, pasta, 
sweets, fried food). The study was conducted on 
participants of the Rush Memory and Aging 
Project (MAP) in Chicago from 2004 until 2014, 
which included 923 people aged 58 to 98. The 
results showed that even moderate adherence 
to the MIND diet has a protective effect, 
significantly lowering the number of AD cases. 
This does not necessarily mean that the MIND 
diet is specifically effective for AD, but that it has 
a protective effect on the brain and general 
functioning (10). Fruit and vegetable 
consumption typical for the Mediterranean diet 
showed a link with lower risk of AD and dementia 
in women, while consumption of fish and 
seafood significantly correlated with lower 
incidence of dementia in general among the 
people of southwestern France (11). The 
Mediterranean diet, alone or in combination with 
other dietary patterns, represents the most 
effective approach to slowing the progression of 
AD with the fewest possible adverse effects (11). 
Persons who adopt this type of diet are less 
likely to develop AD than their peers who do not 
(12). 
Supplements and their role 
Vitamins are important for normal functioning of 
the whole body, including the brain. Therefore, 
the American Food and Drug Administration 
Agency mandated fortification of grains with 
folate from 1996 until 1997 to prevent vitamin 
deficiency (13). It is believed that a deficiency of 
folic acid and other B vitamins, along with 
vitamin C and E deficit, can contribute to the 
development of AD (14). However, results of 
vitamin supplementation are inconsistent. A 
longitudinal cohort study conducted on 965 
people over 65 years in New York (northern 
Manhattan) suggests that lower risk of AD 
development is associated with total folate 
intake from both food and dietary supplements, 
rather than intake from a single source, while 
intake of vitamins B6 or B12 is not linked to or 
significant for the risk of AD (13). Similar results 
were obtained in a cross-sectional study 
conducted on 1219 cognitively healthy people 
older than 65, where no significant link was 
found between lower risk of AD and vitamin B9, 
B12, C, E and β-carotene supplementation (9). A 
longitudinal cross-sectional study conducted on 
4470 participants (the Cache County Study) 
aimed to determine the link between antioxidant 
supplementation and the risk of AD 
development. Previous studies reported that 
vitamins C and E act neuroprotectively and 
lower the risk of AD by scavenging free radicals 
and other reactive oxygen species (15). A 
longitudinal study in Sweden involving 1810 
people older than 75 (Kungsholmen Project), 
conducted from 1987 to 2000, identified that 
lower levels of vitamin B12 and folic acid, 
probably due to malnutrition or malabsorption in 
the elderly, double the risk of AD (16). Vitamins 
B9 and B12, unlike vitamins C and E, regulate 
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homocysteine levels in the blood, which are 
associated with the risk of AD. A multicentre 
randomized double-blind controlled clinical trial 
conducted in America (ADCS) from 2003 until 
2006 on 340 participants reported that high 
dosage of vitamin B6, B12 and folic acid 
supplementation did not delay cognitive 
decline, nor did it improve the clinical status of 
persons with mild or moderate AD (17). The 
discrepancy of results may be due to the 
different mechanisms of action of vitamins in 
prevention of AD, the number of participants and 
their age, the type and duration of the study, pre-
existing vitamin deficiency and the type of 
prevention involved (primary, secondary or 
tertiary). Berti et al. (2015) conducted a cross-
sectional study on 52 participants at risk of 
developing AD from 2013 to 2014 to clarify how 
nutrients are associated with healthy brain aging 
and prevention of AD. The objective was to 
identify how different patterns of nutrition affect 
the formation of Aβ plaques (initial sign of 
pathological changes), glucose metabolism 
(indicator of neuronal activation) and grey matter 
volume of the brain (sign of atrophy). The results 
showed that higher intake of vitamins B12, D and 
Zn reduces Aβ plaque load in the brain, as well 
as increases neuronal activity and grey matter 
volume. Higher activation of neurons was 
registered during higher intake of vitamin E, ω-3 
and ω-6 polyunsaturated fatty acids, vitamins A, 
C and whole grains. Intake of vitamins B 1, 2, 3, 6, 
9 and minerals Ca, Fe, Mg, P, K, Se showed no 
significant effect on the formation of Aβ 
plaques, neuronal activation and grey matter 
atrophy, while higher intake of saturated fatty 
acids, food high in cholesterol and sodium had a 
significant impact on lowering neuronal 
activation and grey matter volume (18). Results 
obtained from a small number of carefully 
screened subjects in another large cohort study 
(Three-City Study) conducted in three French 
cities from 1999 and 2000 until 2012 on 9294 
people, only 666 of whom were non-demented, 
confirmed that there is a strong link between 
lower intake of vitamin D, carotenes and 
polyunsaturated fatty acids, higher intake of 
saturated fatty acids and long-term risk of AD 
and dementia. Future interventional research on 
primary prevention of AD and dementia should 
focus on the optimal combination of nutrients 
based on the results obtained so far (19). 
Polyphenols 
This paper did not focus on the effects of 
polyphenols on animals, only on humans. 
Vitamin P was first mentioned in 1936, and has 
been plentiful in the human diet since then. 
Polyphenols are secondary plant products 
believed to have a positive effect on human 
health, particularly for the elderly (20). 
Polyphenols from different fruit such as 
blueberries, blackberries, grapes and apples, 
from green and black tea, wine, coffee, cocoa 
and from spices such as turmeric and curry 
possess anti-inflammatory, antioxidant and 
neuroprotective properties (21). Research on 
polyphenols in Japan and Singapore has 
indicated that they have the potential to be 
neuroprotective (12), although the underlying 
mechanisms have not been fully clarified. 
Polyphenols interact with a wide range of 
neurotransmitters, suppressing 
neuroinflammation and degeneration through 
direct, indirect or complex action (22). Since 
1936, almost 10 000 articles have been 
published on the chemical nature and biological 
activities of polyphenols (20), suggesting that 
they have a neuroprotective effect. Evidence 
from first-in-human research has identified that 
polyphenols have a positive effect, as part of a 
balanced diet. However, the effects of 
antioxidants have been disputed in the past few 
years. It has been suggested that their 
metabolites do not cross the blood-brain barrier, 
which brings their neuroprotective effect into 
question (20). 
Caloric restrictions 
The average energy requirements for an adult 
person are 25 kcal/kg/day. They decline after 
adolescence because the human body stops 
growing and basal metabolic rate decreases. 
Between the ages of 55 and 75 energy 
requirements decrease by 8% for every decade 
and by an additional 10% for every decade after 
75 (23). Caloric restriction as a way of primary 
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prevention of AD may be used only in those 
individuals with normal eating patterns. 
Malnutrition and weight loss are usually 
associated with the onset of AD; caloric 
restriction would thus be counterproductive (23). 
Discussion  
Although no cure for neurodegenerative 
diseases exists, prevention and delaying the 
onset of the diseases is important. Large cohort 
studies have confirmed the protective role of 
diets like the Mediterranean diet, of a higher 
intake of polyunsaturated instead of saturated 
fatty acids, of a higher intake of fish and of 
vitamin supplementation (24). The role of 
decreased levels of a single nutrient and its 
supplementation in prevention of cognitive 
decline and dementia are eliciting controversy, 
probably because supplements act in a 
synergistic way and single nutrient 
supplementation will not lead to improvement 
(25). Seven lifestyle risk factors have been 
identified in connection with AD. Besides low 
education, physical inactivity, smoking, 
depression and hypertension, the role of 
nutrition is the most controversial and the role of 
sleeping disorders has not been sufficiently 
researched (26). A carefully controlled long-
term interventional study on the effects of diet 
on prevention and delaying the onset of disease 
is required (24), with special consideration given 
to participants, type and duration of study, 
biomarkers for AD and intermediate outcomes 
(26). 
Conclusion 
The most investigated nutrients in regard of AD 
and cognitive decline are ɷ-3 and ɷ-6 
polyunsaturated fatty acids from fish, poultry, 
nuts and margarine, as well as, folic acid, vitamin 
C and E. Consumption of polyphenol-rich foods 
like blueberries, blackberries, grapes, apples or 
beverages such as green and black tea, coffee 
and red wine may be beneficial. Adherence to 
Mediterranean diet is recommended because of 
the protective effect on the brain and general 
functioning. Caloric restriction may be 
counterproductive in elderly. Future intervention 
studies aiming to influence the modifiable 
lifestyle factors and to reduce the number of 
people at risk for AD, or at least slow down 
cognitive decline, are required. 
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